Please login to the form below

Not currently logged in
Email:
Password:

Keith Webber leaves FDA for Perrigo

Switches regulatory agency for biopharma company

Perrigo Company has named former US Food and Drug Administration (FDA) employee Keith Webber as head of its regulatory review process.

Perrigo will benefit from Webber's experience working with the US regulator, including most recently as acting director of the office of the FDA's pharmaceutical science in the Center for Drug Evaluation and Research (CDER), which over-the-counter and prescription drugs.

Prior to this, he oversaw regulation of generic medicines at the FDA as director of office of generic drug. This followed a period serving in several other leadership roles within the FDA.

The role marks a switch to the industry side of pharma for Webber, heading all the Perrigo's regulatory activities for both its consumer healthcare and prescription medicine business.

This includes holding responsibility for advancing the approval of drugs and providing guidance on regulatory strategy for products in development.

Perrigo's Chairman, president and CEO Joseph Papa commented that Webber “brings to us a wealth of strategic, scientific and regulatory experience from his years working with the FDA”.

27th September 2013

From: Sales, Regulatory

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Create Health

A healthcare marketing agency that shares your passion for making things better. Our clients with solve real health problems every...

Latest intelligence

A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....
The relevance of patient perspectives to value
Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....

Infographics